# Adicet Bio, Inc.: filings

ACET · Nasdaq · CIK 1720580 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 26

Pages: [Overview](/companies/acet.md) · [Financials](/companies/acet/financials.md) · [Filings](/companies/acet/filings.md) · [Insiders](/companies/acet/insiders.md)

## Reports and events: 220 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 246, 8-K 148, 3 34, 10-Q 26, SC 13G/A 23, SC 13G 15, 424B5 14, S-8 14, SC 13D/A 14, CORRESP 12, UPLOAD 10, 10-K 9, DEF 14A 9, DEFA14A 9, EFFECT 8, S-3 6, S-8 POS 6, SCHEDULE 13G/A 6, 144 5, 425 5, SC 13D 5, 4/A 4, ARS 4, 10-K/A 3, S-4/A 3, 3/A 2, 424B3 2, 5 2, 8-K/A 2, DRS/A 2, DRSLTR 2, PRE 14A 2, SCHEDULE 13D/A 2, SCHEDULE 13G 2, 424B4 1, 8-A12B 1, CERT 1, CT ORDER 1, DEFR14A 1, DRS 1, S-1 1, S-1/A 1, S-3/A 1, S-3MEF 1, S-4 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-28 | 08:15 ET | [8-K](/filings/0001720580-26-000060.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001720580-26-000060 |
| 2026-09-08 | 16:17 ET | [8-K](/filings/0001720580-26-000056.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001720580-26-000056 |
| 2026-09-01 | 07:02 ET | [8-K](/filings/0001720580-26-000054.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001720580-26-000054 |
| 2026-08-05 | 16:21 ET | [10-Q](/filings/0001720580-26-000050.md) | Quarterly report, period 2026-06-30 | 0001720580-26-000050 |
| 2026-08-05 | 16:18 ET | [8-K](/filings/0001720580-26-000049.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001720580-26-000049 |
| 2026-06-18 | 16:01 ET | [8-K](/filings/0001720580-26-000043.md) | 5.07 Shareholder vote results | 0001720580-26-000043 |
| 2026-05-20 | 16:10 ET | [10-K/A](/filings/0001720580-26-000042.md) | Annual report, amended, period 2025-12-31 | 0001720580-26-000042 |
| 2026-05-13 | 16:32 ET | [10-Q](/filings/0001720580-26-000037.md) | Quarterly report, period 2026-03-31 | 0001720580-26-000037 |
| 2026-05-13 | 16:04 ET | [8-K](/filings/0001720580-26-000036.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001720580-26-000036 |
| 2026-04-29 | 16:02 ET | [DEF 14A](/filings/0001720580-26-000027.md) | Proxy statement, period 2026-04-29 | 0001720580-26-000027 |
| 2026-04-28 | 16:01 ET | [8-K](/filings/0001720580-26-000023.md) | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001720580-26-000023 |
| 2026-04-10 | 20:27 ET | [SCHEDULE 13D/A](/filings/0000947871-26-000427.md) | Ownership report, active investor, amended | 0000947871-26-000427 |
| 2026-03-12 | 16:27 ET | [10-K](/filings/0001720580-26-000008.md) | Annual report, period 2025-12-31 | 0001720580-26-000008 |
| 2026-03-12 | 16:22 ET | [8-K](/filings/0001720580-26-000006.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001720580-26-000006 |
| 2026-01-07 | 08:30 ET | [8-K](/filings/0001193125-26-005486.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-005486 |
| 2025-12-29 | 08:30 ET | [8-K](/filings/0001193125-25-332343.md) | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-332343 |
| 2025-12-19 | 16:02 ET | [8-K](/filings/0001193125-25-326784.md) | 5.07 Shareholder vote results | 0001193125-25-326784 |
| 2025-11-17 | 16:01 ET | [DEF 14A](/filings/0001193125-25-284586.md) | Proxy statement, period 2025-12-19 | 0001193125-25-284586 |
| 2025-11-05 | 16:06 ET | [10-Q](/filings/0001193125-25-266880.md) | Quarterly report, period 2025-09-30 | 0001193125-25-266880 |
| 2025-11-05 | 16:02 ET | [8-K](/filings/0001193125-25-266860.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-266860 |
| 2025-10-10 | 19:55 ET | [SCHEDULE 13D/A](/filings/0000947871-25-000897.md) | Ownership report, active investor, amended | 0000947871-25-000897 |
| 2025-10-07 | 16:01 ET | [8-K](/filings/0001193125-25-233427.md) | 3.01 Delisting notice | 0001193125-25-233427 |
| 2025-10-07 | 07:11 ET | [8-K](/filings/0001193125-25-232558.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-25-232558 |
| 2025-10-07 | 06:48 ET | [8-K](/filings/0001193125-25-232539.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-232539 |
| 2025-08-07 | 16:05 ET | [10-Q](/filings/0000950170-25-104978.md) | Quarterly report, period 2025-06-30 | 0000950170-25-104978 |
| 2025-08-07 | 16:03 ET | [8-K](/filings/0000950170-25-104969.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-104969 |
| 2025-07-23 | 16:01 ET | [8-K](/filings/0000950170-25-097881.md) | 2.05 Exit or disposal costs; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-097881 |
| 2025-06-13 | 16:02 ET | [8-K](/filings/0000950170-25-086120.md) | 5.07 Shareholder vote results | 0000950170-25-086120 |
| 2025-05-06 | 16:07 ET | [10-Q](/filings/0000950170-25-064448.md) | Quarterly report, period 2025-03-31 | 0000950170-25-064448 |
| 2025-05-06 | 16:04 ET | [8-K](/filings/0000950170-25-064423.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-064423 |
| 2025-04-29 | 16:07 ET | [DEF 14A](/filings/0000950170-25-060104.md) | Proxy statement, period 2025-04-29 | 0000950170-25-060104 |
| 2025-04-17 | 07:02 ET | [8-K](/filings/0000950170-25-054995.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-054995 |
| 2025-04-11 | 16:01 ET | [8-K](/filings/0000950170-25-053238.md) | 3.01 Delisting notice | 0000950170-25-053238 |
| 2025-03-06 | 16:04 ET | [10-K](/filings/0000950170-25-034587.md) | Annual report, period 2024-12-31 | 0000950170-25-034587 |
| 2025-03-06 | 16:02 ET | [8-K](/filings/0000950170-25-034580.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-034580 |
| 2025-02-05 | 07:01 ET | [8-K](/filings/0000950170-25-014153.md) | 8.01 Other events | 0000950170-25-014153 |
| 2024-12-19 | 16:00 ET | [8-K](/filings/0000950170-24-138419.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-138419 |
| 2024-11-27 | 17:12 ET | [8-K](/filings/0000950170-24-131609.md) | 1.02 Termination of a material agreement | 0000950170-24-131609 |
| 2024-11-18 | 16:01 ET | [8-K](/filings/0000950170-24-127927.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-127927 |
| 2024-11-15 | 16:03 ET | [8-K](/filings/0000950170-24-127560.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000950170-24-127560 |
| 2024-11-06 | 16:03 ET | [10-Q](/filings/0000950170-24-122253.md) | Quarterly report, period 2024-09-30 | 0000950170-24-122253 |
| 2024-11-06 | 16:01 ET | [8-K](/filings/0000950170-24-122244.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-122244 |
| 2024-10-16 | 07:01 ET | [8-K](/filings/0000950170-24-114839.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-114839 |
| 2024-09-30 | 07:01 ET | [8-K](/filings/0000950170-24-110166.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-110166 |
| 2024-09-19 | 07:01 ET | [8-K](/filings/0000950170-24-107988.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-107988 |
| 2024-09-10 | 07:01 ET | [8-K](/filings/0000950170-24-104915.md) | 8.01 Other events | 0000950170-24-104915 |
| 2024-08-19 | 16:01 ET | [8-K](/filings/0000950170-24-098485.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-098485 |
| 2024-08-13 | 07:04 ET | [10-Q](/filings/0000950170-24-095745.md) | Quarterly report, period 2024-06-30 | 0000950170-24-095745 |
| 2024-08-13 | 07:01 ET | [8-K](/filings/0000950170-24-095744.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-095744 |
| 2024-07-08 | 07:01 ET | [8-K](/filings/0000950170-24-081943.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-081943 |

Page 1 of 5. [Older](/companies/acet/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.